DUBLIN--(BUSINESS WIRE)--The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis 2023 to 2027" report has been added to ResearchAndMarkets.com's offering.
'Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis 2023 to 2027'
The report forecasts the market size out to 2023. The report includes detailed breakouts for 14 countries and 5 regions.
Will all newborns receive Whole Genome Sequencing at birth? How fast will Direct to Consumer Testing grow? What sequencing technology will take the lead? What's holding the industry back? Where are the over 800 locations that have high throughput devices?
The plummeting costs for Whole Genome Sequencing are creating a gold rush for market players. New consumers, new technologies, new specializations. In a situation reminiscent of the birth of the internet industry a wide range of well funded players are racing for market share on a truly global stage.
Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years. All report data is available in Excel format on request. Make investment decisions and valuations with confidence using the latest data.
Market Participants Play Different Roles
Independent lab specialized/esoteric
Independent lab national/regional
Independent lab analytical
Public National/regional lab
Whole Genome Sequencing - Markets, Examples and Discussion
Direct to Consumer - Two Approaches
The New Age of Medical Information
Dangers in DTC-WGS - Health Costs and Regulation
Newborn and Prenatal - A Brave New World
Research Funding and Capital Expense
Existing research repurposed
Service Suppliers Respond
Clinical - Understanding Germline and Somatic
Somatic - Chasing Mutations and Pharmacogenomics
Instrument Manufacturer Role
Healthcare Industry Impacts - Still Struggling
Can the Healthcare Industry Adapt?
Genetic Counselling as an Industry
WGES Adoption and Cannibalization
Interpreting the Code Otherwise
Fertility Technology Comes of Age
Increased Competition Lowers Price
Healthcare Cost Concerns Curtail Growth
Sequencing Instrumentation
Declining Cost Changes Industry Structure
LISTING of CURRENT NGS INSTRUMENT SPECIFICATIONS
What is Oxford Nanopore Sequencing?
What can Oxford Nanopore Sequencing be used for?
Long Reads - Further Segmentation
Targeted Sequencing Adopts CRISPR
New Sequencing Technologies
In vitro virus high-throughput sequencing
Tunnelling currents DNA sequencing
Sequencing by hybridization
Sequencing with mass spectrometry
Microfluidic Sanger sequencing
Microscopy-based techniques
Genomics England, Aims to Sequence 100K Newborns
Aniling Gets CE-IVD Marks for Cancer Sequencing Tests MyOme Lands Investment for WGS
GenomSys Gains CE Mark for New Genomic Analysis Software Plan to Sequence All Newborns in UK
Variantyx Expands Into Prenatal, Cancer Testing Whole-Genome Sequencing Aids Diagnosis in Stockholm
Nonacus WGS Service for SARS-CoV-2 Laboratories
Center to Report Risk Scores in Clinical WGS
Stanford Launches WGS for Cardiovascular Testing Illumina and NY Healthcare Partner on Clinical WGS Increased Adoption of WGS Needs Acceptance by Payors, Providers
M2GEN and Discovery Life Sciences in Bioinformatics Agreement Genomics England Adopts Quantum ActiveScale Object Storage
NHS Wales Introduces WGS for Critically Ill Newborns
Illumina Achieves EAU for NGS-Based SARS-CoV-2 Test UK COVID-19 Sequencing Consortium Launches Experience From Centralized Genomic Medicine Lab
MGI to Enable $100 Human Genome
Team to Study Campylobacter Omics
NEOGEN, Gencove partner to advance animal genomics UK Whole-Genome Sequencing Project Obtains £200M
WGS may help with disease outbreaks
Dante Labs Launches GenomeL, Long Reads Human Whole Genome Sequencing Whole Genome Sequencing for healthy creates controversy
Profiles of Key Companies
Genomics Personalized Health (GPH)
For more information about this report visit https://www.researchandmarkets.com/r/8jd5wb-genome-and?w=4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.